Targeted Therapy in HER2 Exon 20-Mutant Non-small Cell Lung Cancer With Leptomeningeal Disease: A Case-Based Approach to Treatment Decision-Making

Related articles

1. CDX2 Expression Predicts Fluoropyrimidine Sensitivity Across Rare Non-GI Tumors: A Three-Case Series

   This article has 5 authors:

   1. Riham Suleiman
   2. Andrea Dipp Garcia
   3. Binav Baral
   4. Thorvardur R. Halfdanarson
   5. Harry E. Fuentes Bayne

2. Stage Ⅳb Pulmonary Sarcomatoid Carcinoma with EGFR L861Q KRAS Co-mutation and High PD-L1 Expression Neoadjuvant Immunochemotherapy Combined with Surgery Achieves Near MPR

   This article has 10 authors:

   1. Yu-Tao Pang
   2. Hong-Fei Zhang
   3. Ang Li
   4. Yang Fei Peng
   5. Xiao Yang
   6. Dong Wu
   7. Jie Chen
   8. Zhu Liang
   9. Fa-Sheng Li
   10. zhan He

3. Long-Term Sacituzumab Govitecan Treatment in HR+/HER2- Advanced Breast Cancer: A Case Discussion

   This article has 6 authors:

   1. Yilin Lin
   2. Yongxia Dang
   3. Xiaotong Li
   4. Tong Li
   5. Jingru Yang
   6. Xiaoling Ling